[144] ANI PHARMACEUTICALS INC SEC Filing

Rhea-AI Filing Summary

ANIP affiliate submitted a Rule 144 notice to sell 55,000 shares of Common Stock on Nasdaq. The filing lists four planned issuances/allocations tied to performance shares and restricted stock dated 02/11/2026, 02/14/2026, and 03/07/2026. The cover line shows 55,000 shares, a value field of $4,266,563.58, and a reference figure of 22,734,618.

Insights

Securities Compliance Attorney

Rule 144 notice filed for resale of restricted and performance-based shares.

The filing lists a proposed sale quantity of 55,000 shares and identifies specific allocations: 17,482 and 15,555 performance-share items dated 02/11/2026, plus restricted-stock items dated 02/14/2026 and 03/07/2026. The entry also shows $4,266,563.58 adjacent to the share total and a referenced figure of 22,734,618.

These notices are procedural: they signal a planned resale under Rule 144 but do not state execution timing, purchaser identity, or whether the seller is an affiliate or non-affiliate beyond the filing header. Subsequent market activity depends on whether the sales are executed and on filing-related vesting or transfer conditions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	55000	4266563.58	22734618	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Performance Shares	Issuer			17482	02/11/2026	Not Applicable
Common	02/11/2026	Performance Shares	Issuer			15555	02/11/2026	Not Applicable
Common	02/14/2026	Restricted Stock	Issuer			9834	02/14/2026	Not Applicable
Common	03/07/2026	Restricted Stock	Issuer			12129	03/07/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)